▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2688 by analyst upside · 2026-09-27
ARGX
argenx SE
Healthcare · Market Cap $60B · P/E 36.5x
ANALYST PRICE TARGET
+23.0%
implied upside to consensus target
Current Price $959.49
Consensus Target $1180.17
Bull Target $1450.0
Bear Target $900.0
Analysts Covering 23
ANALYST CONSENSUS - BUY
Strong Buy
5
Buy
16
Hold
2
Sell
0
52-Week Low $661.85
52-Week High $1072.75
YTD Return +14.2%
FUNDAMENTALS
Market Cap $60B
P/E Ratio (TTM) 36.5x
Forward P/E 27.6x
EPS (TTM) $26.29
PEG Ratio 1.18
Dividend Yield N/A
Revenue (TTM) $5.3B
Profit Margin 32.3%
52-WEEK RANGE
52-Week Low $661.85
52-Week High $1072.75
Current Price $959.49
Bear Target $900.0
Bull Target $1450.0
● Now $959.49 ● Target $1180.17
TRADING DATA
Avg Volume 285K
YTD Return +14.2%
Analyst Count 23
Consensus Buy
Upside to Target +23.0%
Last Updated 2026-09-27

ANALYST SUMMARY

argenx SE (ARGX) is currently trading at $959.49 with a Wall Street consensus price target of $1180.17, implying potential upside of 23.0% over the next 12 months. 23 analysts currently cover ARGX, with a consensus rating of Buy - 91% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $1450.0, while the most cautious has a target of $900.0.

ARGX operates in the Healthcare sector with a market capitalisation of $60B. The stock is up 14.2% year-to-date and is currently trading near the upper end of its 52-week range of $661.85 – $1072.75.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for ARGX, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Wedbush reit
Outperform → Outperform 2026-09-08 Building track record
Wedbush reit
Outperform → Outperform 2026-09-03 Building track record
Morgan Stanley - Reiterated
Overweight → Overweight 2026-08-31 Building track record
UBS ↑ Upgrade
Neutral → Buy 2026-08-26 33% win rate (6 calls)
Wells Fargo - Reiterated
Overweight → Overweight 2026-08-26 Building track record
Truist Securities - Reiterated
Buy → Buy 2026-08-18 Building track record
Morgan Stanley - Reiterated
Overweight → Overweight 2026-08-18 Building track record
RBC Capital - Reiterated
Outperform → Outperform 2026-08-18 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
65
out of 100
Coverage depth
24/30
Consensus clarity
19/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →